RNA is currently covered by 3 analysts with average potential upside of $15.76 (89.35%) backed by 1 price targets and 14 ratings. Documented since 07-Jul-2020. Analyst's average stock valuation to be materialised ratio is 3.57% with an average time for price targets to be met of 17.25 days.
Most recent stock forecast was given by JUDAH FROMMER from CREDIT SUISSE on 01-Mar-2023.
Highest price target for RNA is 25, Lowest price target is 11, average price target is 18.
Currently, out of the existing stock ratings of RNA - 13 which are a Buy (100%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
35
$15.22 (76.95%)
35
27 days ago
1/7 (14.29%)
$14.47 (86.96%)
69
Buy
27
$7.22 (36.50%)
27
27 days ago
0/3 (0%)
$7.77 (42.70%)
Buy
71
$51.22 (258.95%)
30
3 months 13 days ago
0/4 (0%)
$24.82 (160.91%)
Buy
53
10 months 17 days ago
0/4 (0%)
$15.98 (66.81%)
What is RNA() average time for price targets to be met?
Which analyst has the current highest performing score on RNA() with a proven track record?
